BlackRock Inc. Purchases 375,137 Shares of Calyxt (CLXT)

BlackRock Inc. raised its position in Calyxt (NASDAQ:CLXT) by 102.8% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 740,010 shares of the company’s stock after purchasing an additional 375,137 shares during the period. BlackRock Inc. owned about 2.67% of Calyxt worth $16,302,000 at the end of the most recent reporting period.

A number of other large investors have also recently added to or reduced their stakes in CLXT. Bank of New York Mellon Corp purchased a new position in Calyxt in the 3rd quarter valued at about $542,000. American International Group Inc. purchased a new position in shares of Calyxt during the 3rd quarter worth about $133,000. Schwab Charles Investment Management Inc. purchased a new position in shares of Calyxt during the 3rd quarter worth about $358,000. California State Teachers Retirement System purchased a new position in shares of Calyxt during the 3rd quarter worth about $323,000. Finally, Wells Fargo & Company MN lifted its holdings in shares of Calyxt by 1,421.9% during the 4th quarter. Wells Fargo & Company MN now owns 30,788 shares of the company’s stock worth $678,000 after acquiring an additional 28,765 shares during the period. Institutional investors own 22.06% of the company’s stock.

How to Become a New Pot Stock Millionaire

Several research analysts have recently weighed in on CLXT shares. Zacks Investment Research upgraded shares of Calyxt from a “sell” rating to a “hold” rating in a report on Monday, January 8th. Jefferies Group reiterated a “buy” rating and set a $27.00 price objective on shares of Calyxt in a report on Thursday, March 1st. Finally, ValuEngine upgraded shares of Calyxt from a “sell” rating to a “hold” rating in a report on Wednesday, March 14th. One equities research analyst has rated the stock with a sell rating, two have given a hold rating and four have given a buy rating to the stock. The company has a consensus rating of “Hold” and a consensus price target of $29.05.



In related news, insider Daniel F. Voytas sold 4,083 shares of the stock in a transaction that occurred on Monday, April 9th. The shares were sold at an average price of $14.38, for a total transaction of $58,713.54. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Daniel F. Voytas sold 4,666 shares of the stock in a transaction that occurred on Tuesday, March 20th. The stock was sold at an average price of $17.91, for a total transaction of $83,568.06. Following the sale, the insider now directly owns 4,666 shares of the company’s stock, valued at approximately $83,568.06. The disclosure for this sale can be found here. In the last three months, insiders have sold 108,579 shares of company stock valued at $2,104,642.

Shares of CLXT stock opened at $16.97 on Friday. The stock has a market cap of $487.72 and a PE ratio of -15.15. Calyxt has a 1-year low of $9.26 and a 1-year high of $31.89. The company has a debt-to-equity ratio of 0.18, a quick ratio of 13.52 and a current ratio of 13.52.

Calyxt (NASDAQ:CLXT) last announced its quarterly earnings data on Tuesday, March 13th. The company reported ($0.24) earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.21) by ($0.03). The company had revenue of $0.19 million for the quarter, compared to analysts’ expectations of $0.10 million. Calyxt had a negative return on equity of 75.53% and a negative net margin of 5,164.61%. analysts forecast that Calyxt will post -1.31 earnings per share for the current fiscal year.

TRADEMARK VIOLATION WARNING: This piece of content was first reported by StockNewsTimes and is the property of of StockNewsTimes. If you are accessing this piece of content on another publication, it was illegally copied and republished in violation of United States and international copyright legislation. The legal version of this piece of content can be read at https://stocknewstimes.com/2018/04/20/blackrock-inc-purchases-375137-shares-of-calyxt-clxt.html.

About Calyxt

Calyxt, Inc, a consumer-centric food- and agriculture-focused company, develops healthier specialty food ingredients and food crops using gene-editing technology for plants in the United States. It engages in the development of high oleic soybeans, high fiber wheat, herbicide tolerant wheat, powdery mildew resistant wheat, enhanced oil composition and herbicide tolerant canola, enhanced quality and herbicide tolerant alfalfa, late blight resistant potatoes, and cold storable/reduced browning potatoes, as well as enhanced protein composition, drought tolerant, herbicide tolerant, and enhanced yield soybeans.

Institutional Ownership by Quarter for Calyxt (NASDAQ:CLXT)

Receive News & Ratings for Calyxt Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Calyxt and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply